HELISE BICHEFSKY: Open Payments
NPI 1770533267 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 21 payments from 8 companies in 2025. Trend: 2023 $647 · 2024 $926 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $175 |
| Braeburn Inc. | 4 | $98 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Indivior Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
Products named: VRAYLAR, BRIXADI, UBRELVY, BREZTRI, SUBLOCADE, MOUNJARO, JOURNAVX, FANAPT.
Industry payments across PA — which companies pay providers there.
